Type 2 diabetes mellitus as a risk factor for dementia in a Mexican population

Journal of Diabetes and its Complications

Volumn 30, Issue 7, 2016, Pages 1234-1239

  Salinas, Rosa María ^a   Hiriart, Marcia ^b   Acosta, Isaac ^a   Sosa, Ana Luisa ^a   Prince, Martin J ^c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic diseases; Dementia; Elders; Risk factors; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DEMENTIA; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEXICAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VERY ELDERLY; COMPLICATION; MEXICO; RISK FACTOR;

AGED; AGED, 80 AND OVER; DEMENTIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MEXICO; RISK FACTORS;

EID: 84990990136     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2016.06.005     Document Type: Article

References (50)

1. ADA, American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 36:Suppl. 1 (2013), S67–S74, 10.2337/dc13-S067.
2. ADI, Dementia and risk reduction: An analysis of protective and modifiable factors. World Alzheimer report, 2014, Alzheimer's Disease International, London.
3. Ahtiluoto, S., Polvikoski, T., Peltonen, M., Solomon, A., Tuomilehto, J., Winblad, B., Kivipelto, M., Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study. Neurology 75:13 (2010), 1195–1202, 10.1212/WNL.0b013e3181f4d7f8.
4. American Psychiatric Association, Original edition: Diagnostic and statistical manual of mental disorders 4th text revision: DSM-IV. 1995.
5. Aschner, P., Aguilar-Salinas, C., Aguirre, L., Franco, L., Gagliardino, J.J., de Lapertosa, S.G., Diabetes Atlas, Diabetes in South and Central America: an update. Diabetes Research and Clinical Practice 103:2 (2014), 238–243, 10.1016/j.diabres.2013.11.010.
6. Carro, E., Torres-Aleman, I., Serum insulin-like growth factor I in brain function. Keio Journal of Medicine 55:2 (2006), 59–63.
7. Copeland, J.R., Dewey, M.E., Griffiths-Jones, H.M., A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychological Medicine 16:1 (1986), 89–99.
8. Crane, P.K., Walker, R., Hubbard, R.A., Li, G., Nathan, D.M., Zheng, H., Larson, E.B., Glucose levels and risk of dementia. The New England Journal of Medicine 369:6 (2013), 540–548, 10.1056/NEJMoa1215740.
9. De la Monte, S.M., Wands, J.R., Alzheimer's disease is type 3 diabetes-evidence reviewed. Journal of Diabetes Science and Technology 2:6 (2008), 1101–1113.
10. De la Torre, J.C., Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurology 3:3 (2004), 184–190, 10.1016/S1474-4422(04)00683-0.
11. Dewey, M.E., Copeland, J.R., Diagnosis of dementia from the history and aetiology schedule. International Journal of Geriatric Psychiatry 16:9 (2001), 912–917.
12. Euser, S.M., Sattar, N., Witteman, J.C., Bollen, E.L., Sijbrands, E.J., Hofman, A., Prosper Rotterdam Study, A prospective analysis of elevated fasting glucose levels and cognitive function in older people: Results from PROSPER and the Rotterdam Study. Diabetes 59:7 (2010), 1601–1607, 10.2337/db09-0568.
13. Ferri, C., West, R., Moriyama, T.S., Acosta, D., Guerra, M., Huang, Y., Prince, M.J., Tobacco use and dementia: Evidence from the 1066 dementia population-based surveys in Latin America, China and India. International Journal of Geriatric Psychiatry 26:11 (2011), 1177–1185, 10.1002/gps.2661.
14. Ganguli, M., Chandra, V., Gilby, J.E., Ratcliff, G., Sharma, S.D., Pandav, R., Belle, S., Cognitive test performance in a community-based nondemented elderly sample in rural India: The Indo-U.S. Cross-National Dementia Epidemiology Study. International Psychogeriatrics 8:4 (1996), 507–524.
15. Guerra, M., Ferri, C.P., Sosa, A.L., Sala, S.A., Gaona, C., Gonzales, V., Prince, M., Late-life depression in Peru, Mexico and Venezuela: The 10/66 population-based study. The British Journal of Psychiatry 195:6 (2009), 510–515, 10.1192/bjp.bp.109.064055.
16. Hall, K.S., Hendrie, H.C., Brittain, H.M., Norton, J.A., The development of a dementia screening interview in two distinct languages. International Journal of Methods in Psychiatric Research 3 (1993), 1–28.
17. Hassing, L.B., Johansson, B., Nilsson, S.E., Berg, S., Pedersen, N.L., Gatz, M., McClearn, G., Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: A population-based study of the oldest old. International Psychogeriatrics 14:3 (2002), 239–248.
18. Huang, C.C., Chung, C.M., Leu, H.B., Lin, L.Y., Chiu, C.C., Hsu, C.Y., Chan, W.L., Diabetes mellitus and the risk of Alzheimer's disease: A nationwide population-based study. PloS One, 9(1), 2014, e87095, 10.1371/journal.pone.0087095.
19. Huang, E.S., Liu, J.Y., Moffet, H.H., John, P.M., Karter, A.J., Glycemic control, complications, and death in older diabetic patients: The diabetes and aging study. Diabetes Care 34:6 (2011), 1329–1336, 10.2337/dc10-2377.
20. IDF, Diabetes atlas. 6th ed., 2013, International Diabetes Federation, Brussels, Belgium.
21. JNC-VII, The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program, 2004.
22. Kim, B., Feldman, E.L., Insulin resistance in the nervous system. Trends in Endocrinology and Metabolism 23:3 (2012), 133–141, 10.1016/j.tem.2011.12.004.
23. Kirkman, M.S., Briscoe, V.J., Clark, N., Florez, H., Haas, L.B., Halter, J.B., Swift, C.S., Diabetes in older adults. Diabetes Care 35:12 (2012), 2650–2664, 10.2337/dc12-1801.
24. Llibre Rodriguez, J.J., Ferri, C.P., Acosta, D., Guerra, M., Huang, Y., Jacob, K.S., Prince, M., Prevalence of dementia in Latin America, India, and China: A population-based cross-sectional survey. Lancet 372:9637 (2008), 464–474, 10.1016/S0140-6736(08)61002-8 (PubMed PMID: 18657855; PubMed Central PMCID: PMC2854470).
25. Mejia-Arango, S., Zuniga-Gil, C., Diabetes mellitus as a risk factor for dementia in the Mexican elder population. Revista de Neurologia 53:7 (2011), 397–405.
26. Ohara, T., Doi, Y., Ninomiya, T., Hirakawa, Y., Hata, J., Iwaki, T., Kiyohara, Y., Glucose tolerance status and risk of dementia in the community: The Hisayama study. Neurology 77:12 (2011), 1126–1134, 10.1212/WNL.0b013e31822f0435.
27. Ott, A., Stolk, R.P., Van Harskamp, F., Pols, H.A., Hofman, A., Breteler, M.M., Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53:9 (1999), 1937–1942.
28. Pasternak, R.C., Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults. Cardiology Clinics 21:3 (2003), 393–398.
29. Petersen, R.C., Stevens, J.C., Ganguli, M., Tangalos, E.G., Cummings, J.L., DeKosky, S.T., Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:9 (2001), 1133–1142.
30. Prince, M., Acosta, D., Chiu, H., Scazufca, M., Varghese, M., Dementia Research Group, Dementia diagnosis in developing countries: A cross-cultural validation study. Lancet 361:9361 (2003), 909–917, 10.1016/S0140-6736(03)12772-9.
31. Prince, M., Acosta, D., Ferri, C., Guerra, M., Huang, Y., Jacob, K.S., Dementia Research Group, A brief dementia screener suitable for use by non-specialists in resource poor settings—The cross-cultural derivation and validation of the brief Community Screening Instrument for Dementia. International Journal of Geriatric Psychiatry 26:9 (2011), 899–907, 10.1002/gps.2622.
32. Prince, M., Acosta, D., Ferri, C.P., Guerra, M., Huang, Y., Llibre Rodriguez, J.J., Liu, Z., Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: A 10/66 Dementia Research Group population-based cohort study. Lancet 380:9836 (2012), 50–58, 10.1016/S0140-6736(12)60399-7.
33. Prince, M., Ferri, C.P., Acosta, D., Albanese, E., Arizaga, R., Dewey, M., Uwakwe, R., The protocols for the 10/66 Dementia Research Group population-based research programme. BMC Public Health, 7, 2007, 165, 10.1186/1471-2458-7-165.
34. Prince, M., Llibre Rodriguez, J., Noriega, L., Lopez, A., Acosta, D., Albanese, E., Dementia Research Group, The 10/66 Dementia Research Group's fully operationalised DSM-IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: A population validation study. BMC Public Health, 8, 2008, 219, 10.1186/1471-2458-8-219.
35. Profenno, L.A., Porsteinsson, A.P., Faraone, S.V., Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biological Psychiatry 67:6 (2010), 505–512, 10.1016/j.biopsych.2009.02.013.
36. Reitz, C., Tang, M.X., Luchsinger, J., Mayeux, R., Relation of plasma lipids to Alzheimer disease and vascular dementia. Archives of Neurology 61:5 (2004), 705–714, 10.1001/archneur.61.5.705 (61/5/705 [pii]).
37. Roberts, R.O., Knopman, D.S., Cha, R.H., Mielke, M.M., Pankratz, V.S., Boeve, B.F., Lowe, V.J., Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. Journal of Nuclear Medicine 55:5 (2014), 759–764, 10.2967/jnumed.113.132647.
38. Rusanen, M., Rovio, S., Ngandu, T., Nissinen, A., Tuomilehto, J., Soininen, H., Kivipelto, M., Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: A population-based cardiovascular risk factors, aging and dementia study. Dementia and Geriatric Cognitive Disorders 30:3 (2010), 277–284, 10.1159/000320484.
39. Saczynski, J.S., Siggurdsson, S., Jonsson, P.V., Eiriksdottir, G., Olafsdottir, E., Kjartansson, O., Launer, L.J., Glycemic status and brain injury in older individuals: The age gene/environment susceptibility-Reykjavik study. Diabetes Care 32:9 (2009), 1608–1613, 10.2337/dc08-2300.
40. Salas, A., Acosta, D., Ferri, C.P., Guerra, M., Huang, Y., Jacob, K.S., Prince, M.J., The prevalence, correlates, detection and control of diabetes among older people in low and middle income countries. A 10/66 Dementia Research Group population-based survey. PloS One, 11(2), 2016, e0149616, 10.1371/journal.pone.0149616.
41. Sosa, A.L., Albanese, E., Stephan, B.C., Dewey, M., Acosta, D., Ferri, C.P., Stewart, R., Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: A 10/66 population-based study. PLoS Medicine, 9(2), 2012, e1001170, 10.1371/journal.pmed.1001170.
42. StataCorp, Stata Statistical Software: Release 13. 2013, StataCorp LP, College Station, TX.
43. Steen, E., Terry, B.M., Rivera, E.J., Cannon, J.L., Neely, T.R., Tavares, R., De la Monte, S.M., Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease—Is this type 3 diabetes?. Journal of Alzheimer's Disease 7:1 (2005), 63–80.
44. Taguchi, A., Vascular factors in diabetes and Alzheimer's disease. Journal of Alzheimer's Disease 16:4 (2009), 859–864, 10.3233/JAD-2009-0975.
45. Velayudhan, L., Poppe, M., Archer, N., Proitsi, P., Brown, R.G., Lovestone, S., Risk of developing dementia in people with diabetes and mild cognitive impairment. The British Journal of Psychiatry 196:1 (2010), 36–40, 10.1192/bjp.bp.109.067942.
46. Verdile, G., Fuller, S.J., Martins, R.N., The role of type 2 diabetes in neurodegeneration. Neurobiology of Disease 84 (2015), 22–38, 10.1016/j.nbd.2015.04.008.
47. WHO, IDF, Screening for type 2 diabetes. Department of Noncommunicable Diasease Management, 2003, World Health Organization / International Diabetes Federation, Geneva.
48. Xu, W.L., Qiu, C.X., Wahlin, A., Winblad, B., Fratiglioni, L., Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Neurology 63:7 (2004), 1181–1186.
49. Yaffe, K., Falvey, C., Hamilton, N., Schwartz, A.V., Simonsick, E.M., Satterfield, S., Harris, T.B., Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Archives of Neurology 69:9 (2012), 1170–1175, 10.1001/archneurol.2012.1117.
50. Zou, G., A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 159:7 (2004), 702–706.